Associations of physical activity and sedentary behavior with insomnia in middle-aged and older adults: a cross-sectional study
Related Experiment Video
Updated: Jan 7, 2026

Multi-Modal Home Sleep Monitoring in Older Adults
Published on: January 26, 2019
Yiying Lu1, Min Liu1, Sijing Chen2
1Wuhan Children's Hospital (Wuhan Maternal and Child Healthcare Hospital), Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Objective:
To explore the relationships between physical activity (PA) and sedentary behavior (SB) levels and insomnia among middle-aged and older adults.
Methods:
This cross-sectional study involved 3,752 middle-aged and older adults aged 50 years or older from Wuhan, China. PA and SB levels were assessed via the International Physical Activity Questionnaire (IPAQ)-Short Form. Insomnia severity was evaluated by the Insomnia Severity Index (ISI). Multivariate logistic regression was employed to estimate the impact of PA and SB on insomnia.
Results:
A total of 3,752 middle-aged and older adults in Wuhan were included. Among them, 18.0% reported insomnia symptoms, with 13.6% classified as mild insomnia and 4.4% as moderate-to-severe insomnia. After adjustment for confounders, high levels of physical activity were found to be associated with lower odds ratios for mild insomnia than low levels of PA (OR (95% CIs) = 0.67 (0.50, 0.90)), whereas 3-6 h/day and ≥6 h/day of sedentary behavior were associated with higher odds ratios for mild insomnia than were <3 h/day of sedentary behavior (OR (95% CIs) = 1.41 (1.09, 1.83) and 1.71 (1.19, 2.45), respectively). Similarly, moderate and high levels of physical activity were associated with lower odds ratios for moderate insomnia (OR (95% CIs) = 0.45 (0.28, 0.72) and 0.47 (0.30, 0.73), respectively), whereas ≥6 h per day of sedentary behavior was associated with higher odds ratios for moderate insomnia (OR (95% CIs) = 2.47 (1.37, 4.45)).
Conclusion:
High PA levels were associated with a reduced risk of both mild and moderate-to-severe insomnia in middle-aged and older adults, while SB ≥ 3 h/day increased insomnia risk-with the highest risk observed at SB ≥ 6 h/day. Clinically, these findings support non-pharmacological interventions for insomnia prevention and management in this population: recommending achievement of high PA levels (e.g., ≥1,500 MET-minutes/week of vigorous activity or ≥3,000 MET-minutes/week of combined activity) and limiting daily SB to <3 h. Targeted PA/SB intervention programs should be prioritized for high-risk subgroups, such as women and low-income individuals.
Related Concept Videos
Insomnia
Multiple factors contribute...
Insufficient Sleep and Sleep Deprivation
Sleep deprivation is a more severe form of sleep loss...
Management of Insomnia
Substance Use Disorders Affecting Sleep
Understanding the concepts of physical dependence,...
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Sleepwalking and Sleep Talking
Factors that increase the likelihood of sleepwalking include sleep deprivation and alcohol consumption. Contrary to common beliefs, it is safe...

